Amy Z. Crepeau, M.D.

Closed for Enrollment

• A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated with Lennox-Gastaut Syndrome in Children and Adults Scottsdale/Phoenix, Ariz.

  The purpose of this study is to investigate the effectiveness and safety of the potential anti-seizure effects of cannabidiol (GWP42003-P) in children and adults with Lennox-Gastaut syndrome.

• An Open Label Extension Study to Investigate the Safety of Cannabidiol (GWP42003-P; CBD) in Children and Young Adults with Inadequately Controlled Dravet or Lennox-Gastaut Syndromes Scottsdale/Phoenix, Ariz.

  The purpose of this extension study is to investigate the safety of using cannabidiol in children and young adults with Dravet or Lennox-Gastaut syndromes that are not well controlled.